US Patent 8343992 Synthesis of
Patent 8343992 was granted and assigned to Progenics Pharmaceuticals on January, 2013 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 8343992 Synthesis of
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.